Diabetes-Focused Health Care Utilization Among Adolescents and Young Adults With Type 1 Diabetes

• Published in: Academic pediatrics 2024-01, Vol.24 (1), p.59-67
• Main Authors: Wisk, Lauren E., Garvey, Katharine C., Fu, Christina, Landrum, Mary Beth, Beaulieu, Nancy D., Chien, Alyna T.
• Format: Article
• Language: English
• Subjects: adolescence; Adolescent; Child; Diabetes Mellitus, Type 1 - therapy; Glycated Hemoglobin; health care transition; health care utilization; Humans; Patient Acceptance of Health Care; type 1 diabetes mellitus; Young Adult
• ISSN: 1876-2859; 1876-2867
• DOI: 10.1016/j.acap.2023.05.001

To describe the current rates of health services use with various types of providers among adolescents and young adults (AYA) with type 1 diabetes (T1D) and evaluate which patient factors are associated with rates of service use from different provider types. Using 2012–16 claims data from a national commercial insurer, we identified 18,927 person-years of AYA with T1D aged 13 to 26 years and evaluated the frequency at which: 1) AYA skipped diabetes care for a year despite being insured; 2) received care from pediatric or non-pediatric generalists or endocrinologists if care was sought; and 3) received annual hemoglobin A1c (HbA1c) testing as recommended for AYA. We used descriptive statistics and multivariable regression to examine patient, insurance, and physician characteristics associated with utilization and quality outcomes. Between ages 13 and 26, the percentage of AYA with: any diabetes-focused visits declined from 95.3% to 90.3%; the mean annual number of diabetes-focused visits, if any, decreased from 3.5 to 3.0; receipt of ≥2 HbA1c tests annually decreased from 82.3% to 60.6%. Endocrinologists were the majority providers of diabetes care across ages, yet the relative proportion of AYA whose diabetes care was endocrinologist-dominated decreased from 67.3% to 52.7% while diabetes care dominated by primary care providers increased from 19.9% to 38.2%. The strongest predictors of diabetes care utilization were younger age and use of diabetes technology (pumps and continuous glucose monitors). Several provider types are involved in the care of AYA with T1D, though predominate provider type and care quality changes substantially across age in a commercially-insured population.